Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search Stock, IPO, MF
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
Charts & Report
Charts and Graphs
Stock Report Pdf
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Cipla Ltd.
NSE: CIPLA
|
BSE: 500087
|
ISIN: INE059A01026
|
Industry: Pharmaceuticals
US FDA Approval
|
Turnaround Potential
1474.3000
29.70
(
2.06
%)
NSE
Jul 29, 2026
15:31 PM
26.47% Gain from 52W Low
Volume:
2.2M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Cipla Ltd.
04 Dec 2024
US FDA Approval
1474.30
2.06%
CIPLA LTD
Buy:
Cipla Ltd.
by
Geojit BNP Paribas
Target: 1695
Target
Geojit BNP Paribas
Cipla Ltd. is trading above all available SMAs
More from Cipla Ltd.
Recommended
Market closes higher, led by gains in metal and IT stocks
Trendlyne Marketwatch |
29 Jul 2026, 03:57PM
Five stocks to buy from analysts this week - July 28, 2026
The Baseline |
28 Jul 2026, 05:08PM
Indian market boosts Cipla in Q4 despite inventory write-off, new product launches will be key
|
20 May 2022